Maqola

Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1

Zhenzhu SunThe First Clinical Medical College, Wenzhou Medical University, Wenzhou 325000, Zhejiang, ChinaWenqiang LuZhejiang University School of Medicine, Hangzhou, ChinaNa LinZhejiang Chinese Medical University, Hangzhou, ChinaHui LinDepartment of Cardiology, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing 312000, Zhejiang, ChinaJie ZhangShaoxing People's HospitalTingjuan NiZhejiang University School of Medicine, Hangzhou, ChinaLiping MengShaoxing People's HospitalChuanjing ZhangZhejiang University School of Medicine, Hangzhou, ChinaHangyuan GuoThe First Clinical Medical College, Wenzhou Medical University, Wenzhou 325000, Zhejiang, China

2020en

Ochiq kirish: yoʻq

ABI

Annotatsiya

Annotatsiya mavjud emas.

Identifikatorlar

DOI: 10.1016/j.bcp.2020.113888

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba